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Cerebral Palsy due to Intracranial Hemorrhage 
Caused by Consumptive Coagulopathy in Protein C 
Deficiency: A Case Report
Protein C (PROC) is a potent anticoagulant inactivating coagulation factors Va and 
VIIIa. PROC deficiency is very rare condition inherited as an autosomal dominant 
or recessive trait, and associated with various thromboembolic and ischemic 
conditions. Moreover, severe form of PROC deficiency can cause fatal hemorrhagic 
complications due to consumptive coagulopathy. We reported two children with 
hemorrhagic stroke who were diagnosed as severe PROC deficiency caused by two 
different types of compound heterozygous PROC gene mutations.  We described 
results of laboratory tests, genetic analysis, brain magnetic resonance images, and 
functional outcomes. Both children received prophylactic anticoagulation therapy 
and presented with purple-colored skin lesions during rehabilitation. Purpura 
fulminans caused by insufficient anticoagulation should be differentiated from 
hematoma caused by excessive anticoagulation therapy in these children.
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Introduction
Non-progressive damage to the immature brain is a basic pathomechanism of 
cerebral palsy (CP), a group of disorders associated with movement and posture 
abnormalities1). Multiple etiologies including congenital malformation, cerebral 
infarction, and hemorrhage can cause CP. In rare cases, perinatal stroke can result 
from inherited thrombotic pathology such as coagulation factor deficiency2).
Protein C (PROC) is a potent anticoagulant that inactivates coagulation factors 
Va and VIIIa. PROC deficiency can be inherited as an autosomal dominant or 
recessive trait. Thrombophilic disease resulting from a heterozygous PROC gene 
mutation usually presents as a thromboembolic event such as deep vein throm-
bosis or ischemia. Homozygous or compound heterozygous mutations 
sometimes result in severe disseminated intravascular coagulation and 
consumptive coagulopathy3,4). The estimated prevalence of severe PROC 
deficiency, which is derived from population carrier rates of PROC gene 
mutations, is 1 in 4,000,000 people3).Considering the birth rate in Korea, PROC 
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deficiency occurs in about one birth every 10 years5).
From a previous report in Korea, some patients with PROC 
deficiency presented with ischemic stroke; these patients had 
mild PROC deficiency and heterozygotic mutations6). However, 
to our knowledge, there has been no report about hemorrhagic 
stroke caused by consumptive coagulopathy in children with 
severe PROC deficiency. Here, we report two cases of children 
with PROC deficiency who were diagnosed with spastic CP 




A 4-day-old female infant without any perinatal complications 
was referred to the pediatric department for skin color changes 
on both feet (Fig. 1). Based on abnormal coagulation test results, 
PT/aPTT 13.4 sec/44 sec (normal range: 10.0–15.3/25.4–59.8), 
Fibrinogen 58 mg/dL (normal range: 162–462 mg/dL), D-dimer 
62.5 mcg/mL (normal range: 0–0.65 mcg/ml), protein S 68% 
(normal range: 50–130%), and PROC < 0.01 IU/mL, which was 
lower than 1% of normal PROC level at the date of admission, 
and follow up study showed prolongation of PT/aPTT (23.9 
sec/84.4 sec). Also the bloody cerebrospinal fluid was detected, 
PROC deficiency was diagnosed. Brain magnetic resonance 
imaging (MRI) showed subarachnoid and intraventricular 
hemorrhage with ventriculomegaly (Fig. 2A); subsequently, she 
received a ventriculoperitoneal shunt at 6 months old (Fig. 2B).
Genetic evaluation revealed compound heterozygous PROC 
gene mutations: a missense mutation (Arg211Trp) and a frame-
shift mutation (Gly239Serfs*8). Although the infant’s parents had 
no personal or family history of venous thromboembolic 
disease, the mother had a missense mutation (Arg211Trp) at 
2q14.3 and the father had a frameshift mutation (Leu242Prots) at 
2q14.3. The infant received protein C concentrates replacement 
and the level of protein C was increased. She was referred to the 
rehabilitation department at 8 months of age after prescription 
of regular prophylactic low-molecular-weight heparin (LMWH) 
injections.
The infant had hypertonia in all four extremities; she was 
unable to control her neck movement and make eye contact, 
which corresponded to gross motor function classification 
system (GMFCS) level V, manual ability classification system 
(MACS) level V, and communication function classification 
system (CFCS) level V at 9 months old. During rehabilitation, 
both of her thighs became swollen and abruptly turned purple 
(Fig. 3). Hematoma was suspected initially, but the lesion 
expanded after tapering down LMWH. The lesion resolved after 
increasing the LMWH dosage; subsequently, purpura fulminans 
was diagnosed.
Case 2
A 7-day-old female infant presented with a hyperechoic lesion 
with cystic change on the bilateral frontal lobe upon fetal 
sonography. Upon coagulation factor analysis, PT/aPTT (12.3 
sec/36.2 sec) was normal and D-dimer was increased to 1,016 
Fig. 1. Case 1 infant: A female infant was admitted to the hospital 4 days 
after birth. Skin color changes are observed in both feet.
Fig. 2. Case 1 infant: Brain magnetic resonance images show bilateral 
hydrocephalus caused by intraventricular hemorrhage and subarachnoid 
hemorrhage in a fast-spin echo image (A) and decreased size of ventricles 
after ventriculoperitoneal shunt is observed (B). 
Fig. 3. Case 1 infant: Purpura fulminans developed on the infant’s right 
thigh (A) and left thigh (B) during rehabilitation at 10 months old.
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ng/mL (normal range : 0–243 ng/mL), Fibrinogen (225 mg/dL) 
was within normal range and PT/aPTT was prolonged to 18.2 
sec/55.7 sec at follow up study. Also PROC (0.03 IU/mL, 3%) and 
protein S levels (0.47 IU/mL, 47%) were significantly lower than 
normal. Brain MRI revealed intracerebral hemorrhage, hydroce-
phalus, and vitreous hemorrhage with retinal detachment (Fig. 
4A, 4B). Genetic evaluation showed compound heterozygous 
PROC gene mutations: a missense mutation (Arg211Gly) and an 
insertion mutation (718dupG).
Although the infant received regular LMWH injections, she 
represented with purple-colored skin lesions on the head and 
both feet 13 days after birth (Fig. 5). Because the lesions were 
hard with accompanying necrotic tissue, we diagnosed purpura 
fulminans; the lesions resolved after increasing the LMWH dose. 
After ventriculoperitoneal shunt surgery at 5 months old for 
aggravating hydrocephalus, the infant exhibited sudden growth 
of a hygroma on the cerebral falx and in the subdural space (Fig. 
4C). The shunt valve pressure was increased and the hygroma 
had nearly resolved upon follow up neurosonography (Fig. 4D). 
The infant had hypertonia in all four extremities; she was 
unable to control her neck movement and make eye contact, 
corresponding to GMFCS level V, MACS level V, and CFCS level V 
at 3 months old; she started post-operative rehabilitation. 
Discussion
The PROC gene is located on chromosome 2, at 2q13-q14, 
which comprises nine exons4). Common presentations of 
protein C deficiency developing at neonatal period are intracra-
nial thrombosis and hemorrhage followed by purpura fulminans 
that usually lead to death7). These two infants had compound 
heterozygous PROC gene mutations and presented with skin 
lesions typical of purpura fulminans. We believe these infants 
developed consumptive coagulopathy due to PROC deficiency, 
which eventually caused massive intracerebral hemorrhages 
resulting in severe bilateral spastic CP corresponding to GMFCS 
level V.
Patients identified with severe PROC deficiency should be 
treated with long-term anticoagulant therapy to prevent further 
Fig. 5. Case 2 infant: Purpura fulminans is detected on both feet (A) and 
the head (B) of a female neonate at 13 days of age.
Fig. 4. Case 2 infant: Brain magnetic resonance images (T2-weighted images) show bilateral intracerebral hemorrhage 
before ventriculo peritoneal shunt surgery in the frontal lobe (A, B), and intraventricular, subarachnoid, and vitrous 
hemorrhages in T2-weighted flair image (C).
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damage to the vessels. Several anticoagulant drugs are available; 
warfarin is commonly used, although it can induce skin necrosis. 
PROC is a vitamin K-dependent protein; the activated form of 
PROC acts as an anticoagulant by inactivating factors Va and 
VIIIa8). Thus, patients with PROC deficiency are at a greater risk 
of warfarin-induced skin necrosis because additional warfarin is 
prescribed to compensate for the further loss of PROC. Many 
authors propose LMWH for life-long anticoagulation8). LMWH is 
conveniently administered by injection and does not require 
monitoring. Patients with severe PROC deficiency can be 
administered PROC concentrate/replacement, although this 
treatment is very expensive and not currently popular3).
Range of motion exercises commonly used during rehabilita-
tion programs should be performed with caution because they 
might cause hematomas in patients with bleeding tendency. The 
hematoma was developed at frequently physical contacted area, 
but the character of purpura fulminans was painful and showed 
irregular margin and progressed abruptly necrotic change at 
palm, sole and thigh7). Moreover, in patients with PROC defi-
ciency, purpura fulminans caused by insufficient anticoagulation 
should be differentiated from hematoma caused by excessive 
anticoagulation therapy. The treatments of these two lesions are 
completely different, with reduction in the dose of anti-
coagulants to treat hematoma and increase in the dose of 
anticoagulants in purpura fulminans to prevent consumptive 
coagulopathy.
Thromboembolic disease can cause ischemic and hemor-
rhagic stroke in pediatric patients. Therefore, we recommend 
performing coagulation factor assays in children who experi-
ence stroke of unknown etiology. During rehabilitation, any 
change in skin color should be carefully evaluated to differen-
tiate purpura fulminans due to consumptive coagulopathy from 
hematoma due to excessive anticoagulation. 
요약
Protein C는 응고인자 Va와 VIIIa를 비활성시키는 항응고 인자로써 
PROC 결핍은 매우 희귀한 질환으로 열성유전이 되며 다양한 혈전성 
또는 허혈성 질환을 일으킬 수 있는 것으로 알려져 있다. 심한 경우에 
는 소모성 응고병증 상태를 야기시켜 사망에 이르게 할 수도 있다. 우 
리는 본 논문을 통하여 합성이질접합형(compound heterozy gous) 
으로 유전된 PROC 결핍 환자에서 소모성 응고병증으로 인한 출혈성 
뇌졸중 환아 두 명을 기술하였고, 진단검사와 유전자검사, 뇌 자기공 
명영상 이미지와 기능적 상태를 함께 분석하였다. 또한 PROC 결핍 환 
자에서 발생할 수 있는 합병증 중 전격성 자반 피부병변을 소개하여 
항응고인자 투약치료로 인하여 발생가능한 혈종과 구별이 필요함을 
소개하고자 하였다.  
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